Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,626 | 25,900 | 75,627 | 24,897 | 23,187 |
| Marketable Securities | 121,962 | 129,083 | 106,750 | 59,065 | 54,428 |
| Receivables | 890 | 12 | 104 | 44 | 32 |
| TOTAL | $139,946 | $156,430 | $184,453 | $85,114 | $78,810 |
| Non-Current Assets | |||||
| PPE Net | 8,814 | 7,338 | 7,131 | 7,205 | 7,566 |
| Intangibles | 32,038 | 32,291 | 32,545 | 32,798 | 33,052 |
| Other Non-Current Assets | 157 | 174 | 236 | 424 | 409 |
| TOTAL | $41,009 | $39,803 | $39,912 | $40,427 | $41,027 |
| Total Assets | $180,955 | $196,233 | $224,365 | $125,541 | $119,837 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,006 | N/A | 5,630 | 5,592 | 5,693 |
| Accounts payable and accrued liabilities | 1,982 | 2,069 | 2,451 | 745 | 1,281 |
| Accrued Expenses | 13,807 | 9,904 | 9,692 | 10,960 | 8,157 |
| Other current liabilities | N/A | 530 | 557 | 388 | N/A |
| TOTAL | $16,795 | $12,503 | $18,330 | $17,685 | $15,131 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 4,426 | 5,746 | 7,326 |
| Other Non-Current Liabilities | 7,415 | 6,636 | 6,668 | 6,336 | 6,365 |
| TOTAL | $7,415 | $6,636 | $11,094 | $12,082 | $13,691 |
| Total Liabilities | $24,210 | $19,139 | $29,424 | $29,767 | $28,822 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,410 | 5,402 | 5,394 | 5,376 | 4,134 |
| Common Shares | 81 | 81 | 81 | 64 | 61 |
| Retained earnings | -323,617 | -300,477 | -281,461 | -264,129 | -247,322 |
| Other shareholders' equity | 2,686 | 2,548 | 2,689 | 2,745 | 2,775 |
| TOTAL | $156,745 | $177,094 | $194,941 | $95,774 | $91,015 |
| Total Liabilities And Equity | $180,955 | $196,233 | $224,365 | $125,541 | $119,837 |